PMCB

PMCB

USD

PharmaCyte Biotech Inc. Common Stock

$0.890-0.010 (-1.111%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.900

Máximo

$0.917

Mínimo

$0.880

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

6.0M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.10M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.8Actual $0.890Máximo $1.94

Noticias Relacionadas

BusinessWire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure Technologies PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

Ver más
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
BusinessWire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in

Ver más
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
BusinessWire

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of

Ver más
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.